n-acetyl bpc 157 What is BPC-157? N-Acetyl-l-cysteine (NAC), BPC-157, and BPC-157

10.1016/j.cmet.2019.07.013

Lipotropic injections complement GLP-1 medications by supporting liver function and fat metabolism during the accelerated fat loss that GLP-1 drugs produce

BPC-157, by contrast, concentrates effects at the injection site while providing additional systemic benefits

Anyone who has a poor diet, GI disorder, gut dysbiosis (imbalanced gut microbiome), or gut inflammation will not be able to absorb oral vitamins

Cardiovascular considerations exist with both classes of compounds

Here is the honest version, and it is the one clinicians should be giving patients: MIC lipotropic injections are not a proven driver of meaningful fat loss on their own